Use of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer Is Low Among Major European Centres: Results of a Feasibility Questionnaire

被引：68
|
作者：
Burger, Maximilian [1 ]
Mulders, Peter [2 ]
Witjes, Wim [3 ]
机构：
[1] Univ Erlangen Nurnberg, Dept Urol, D-91054 Erlangen, Germany
[2] Radboud Univ Nijmegen, Dept Urol, Nijmegen Med Ctr, NL-6525 ED Nijmegen, Netherlands
[3] EAU Cent Res Off, Arnhem, Netherlands
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 05期
关键词：
D O I：
10.1016/j.eururo.2012.01.039
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1070 / 1071
页数：3
相关论文
共 50 条
  • [1] Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
    van Hoogstraten, Lisa M. C.
    Man, Calvin C. O. L.
    Witjes, J. Alfred R.
    Meijer, Richard M.
    Mulder, Sasja
    Smilde, Tineke
    Ripping, Theodora
    Kiemeney, Lambertus P.
    Aben, Katja K. H.
    BlaZIB Study Grp
    WORLD JOURNAL OF UROLOGY, 2023, 41 (07) : 1837 - 1845
  • [2] Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Lisa M. C. van Hoogstraten
    Calvin C. O. Man
    J. Alfred Witjes
    Richard P. Meijer
    Sasja F. Mulder
    Tineke J. Smilde
    Theodora M. Ripping
    Lambertus A. Kiemeney
    Katja K. H. Aben
    World Journal of Urology, 2023, 41 : 1837 - 1845
  • [3] Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Carvalho, Filipe L. F.
    Zeymo, Alexander
    Egan, Jillian
    Kelly, Colleen H.
    Zheng, Chaoyi
    Lynch, John H.
    Hwang, Jonathan
    Stamatakis, Lambros
    Krasnow, Ross E.
    Kowalczyk, Keith J.
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 390 - 396
  • [4] Feasibility and efficacy of gemcitabine and carboplatin neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Koie, T.
    Yamamoto, H.
    Okamoto, A.
    Hatakeyama, S.
    Momose, A.
    Iwabuchi, I.
    Yoneyama, T.
    Hashimoto, Y.
    Kamimura, N.
    Ohyama, C.
    Saijo, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] Neoadjuvant and Adjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
    Calabro, Fabio
    Sternberg, Cora N.
    EUROPEAN UROLOGY, 2009, 55 (02) : 348 - 358
  • [6] Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer
    Huo, Jinhai
    Ray-Zack, Mohamed D.
    Shan, Yong
    Chamie, Karim
    Boorjian, Stephen A.
    Kerr, Preston
    Jana, Bagi
    Freedland, Stephen J.
    Kamat, Ashish M.
    Mehta, Hemalkumar B.
    William, Stephen B.
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (05): : 497 - 504
  • [7] Contemporary best practice in the use of neoadjuvant chemotherapy in muscle-invasive bladder cancer
    Marcq, Gautier
    Jarry, Edouard
    Ouzaid, Idir
    Hermieu, Jean-Francois
    Henon, Francois
    Fantoni, Jean-Christophe
    Xylinas, Evanguelos
    THERAPEUTIC ADVANCES IN UROLOGY, 2019, 11 : 1 - 8
  • [8] Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Faraj, Kassem S.
    Navaratnam, Anojan K.
    Eversman, Sarah
    Elias, Laila
    Syal, Amit
    Tyson, Mark D.
    Castle, Erik P.
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1111 - 1118
  • [9] Use of treatment pathway improves neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Kassem S. Faraj
    Anojan K. Navaratnam
    Sarah Eversman
    Laila Elias
    Amit Syal
    Mark D. Tyson
    Erik P. Castle
    International Urology and Nephrology, 2021, 53 : 1111 - 1118
  • [10] Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Lyon, Timothy D.
    Frank, Igor
    Takahashi, Naoki
    Boorjian, Stephen A.
    Moynagh, Michael R.
    Shah, Paras H.
    Tarrell, Robert F.
    Cheville, John C.
    Viers, Boyd R.
    Tollefson, Matthew K.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 216 - +
12345